Provided by Tiger Fintech (Singapore) Pte. Ltd.

AIM ImmunoTech Inc.

2.57
-0.0400-1.53%
Post-market: 2.620.0492+1.91%19:01 EDT
Volume:24.93K
Turnover:64.32K
Market Cap:6.96M
PE:-0.11
High:2.66
Open:2.63
Low:2.55
Close:2.61
52wk High:20.35
52wk Low:2.33
Shares:2.71M
Float Shares:2.65M
Volume Ratio:0.35
T/O Rate:0.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-24.1217
EPS(LYR):-30.9192
ROE:-3138.91%
ROA:-104.62%
PB:-1.06
PE(LYR):-0.08

Loading ...

Octopus AIM VCT 2 Announces New Fundraising Initiative

TIPRANKS
·
Oct 17

Hargreave Hale AIM VCT Announces Share Purchase and Cancellation

TIPRANKS
·
Oct 10

Future Metals NL to Cancel AIM Listing, Focus on ASX

TIPRANKS
·
Oct 07

Ascendiant Reaffirms Their Buy Rating on AIM ImmunoTech (AIM)

TIPRANKS
·
Oct 06

HSS Hire Resumes Trading on AIM After Annual Report Release

TIPRANKS
·
Oct 06

AIM ImmunoTech Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Oct 03

Helping Small Businesses in Southeast Asia Tap into AI: ASEAN Foundation and AVPN Introduce Local Partners for AIM ASEAN Programme

prnewswire
·
Oct 03

Petra Capital Reaffirms Their Buy Rating on Ai-Media Technologies Limited (AIM)

TIPRANKS
·
Oct 02

Octopus AIM VCT Director Takes on New Roles at Surgical Innovations

TIPRANKS
·
Oct 01

Oberon AIM VCT Reports Strong First Half Performance with 9% NAV Growth

TIPRANKS
·
Sep 30

Smarttech247 Announces Year-End Update and Proposed AIM Delisting

TIPRANKS
·
Sep 26

Investors Appear Satisfied With Ai-Media Technologies Limited's (ASX:AIM) Prospects As Shares Rocket 55%

Simply Wall St.
·
Sep 26

Octopus AIM VCT 2 Announces Share Buyback and Updated Voting Rights

TIPRANKS
·
Sep 26

AIM ImmunoTech secures patent in Japan through 2039 for therapy using Ampligen

TIPRANKS
·
Sep 25

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors

GlobeNewswire
·
Sep 25

Hargreave Hale AIM VCT Announces Share Purchase and Cancellation

TIPRANKS
·
Sep 24

Pan African Resources to Transition from AIM to London Main Market

TIPRANKS
·
Sep 23

AIM ImmunoTech Announces Publication of Journal Article On the Positive Effect of Ampligen and Interferon-Alpha on Tumor Growth

GlobeNewswire
·
Sep 22

Hargreave Hale AIM VCT Announces Share Purchase and Cancellation

TIPRANKS
·
Sep 17

LifeSafe Holdings to Delist from AIM and Re-register as Private Company

TIPRANKS
·
Sep 12